Howard Trachtman

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. doi Renal and neurological involvement in typical Shiga toxin-associated HUS
    Howard Trachtman
    Department of Pediatrics, Division of Nephrology, NYU Langone Medical Center, Clinical Translational Science Institute, Room 712, 227 East 30th Street, New York, NY 10016 9196, USA
    Nat Rev Nephrol 8:658-69. 2012
  2. pmc Association of histologic variants in FSGS clinical trial with presenting features and outcomes
    Vivette D D'Agati
    Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York, USA
    Clin J Am Soc Nephrol 8:399-406. 2013
  3. pmc A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
    Howard Trachtman
    Division of Nephrology, Department of Pediatrics, Cohen Children s Medical Center, New Hyde Park, New York, USA
    Kidney Int 79:1236-43. 2011
  4. pmc Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab
    CHRISTINE SETHNA
    Division of Nephrology, Department of Pediatrics, Cohen Children s Medical Center of New York, 269 01 76th Avenue, New Hyde Park, NY 11040, USA
    J Transplant 2011:389542. 2011
  5. pmc Clinical trial of focal segmental glomerulosclerosis in children and young adults
    Debbie S Gipson
    Division of Nephrology, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA
    Kidney Int 80:868-78. 2011
  6. doi Evaluation of pediatric patients with mild-to-moderate hypertension: yield of diagnostic testing
    Jonathan Wiesen
    Division of Nephrology, Department of Pediatrics, Schneider Children s Hospital of North Shore LIJ Health System, Long Island Campus, Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA
    Pediatrics 122:e988-93. 2008
  7. doi Nephrotic-range proteinuria in a child with retinoic acid syndrome
    Christine B Sethna
    Division of Nephrology, Department of Pediatrics, Cohen Children s Medical Center of New York, 269 01 76th Avenue, New Hyde Park, NY 11040, USA
    Pediatr Nephrol 27:485-8. 2012

Collaborators

Detail Information

Publications7

  1. doi Renal and neurological involvement in typical Shiga toxin-associated HUS
    Howard Trachtman
    Department of Pediatrics, Division of Nephrology, NYU Langone Medical Center, Clinical Translational Science Institute, Room 712, 227 East 30th Street, New York, NY 10016 9196, USA
    Nat Rev Nephrol 8:658-69. 2012
    ..We describe the experience with eculizumab under these emergent circumstances at one large centre...
  2. pmc Association of histologic variants in FSGS clinical trial with presenting features and outcomes
    Vivette D D'Agati
    Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York, USA
    Clin J Am Soc Nephrol 8:399-406. 2013
    ..The FSGS Clinical Trial provided a unique opportunity to study the clinical impact of histologic variants in a well defined prospective cohort with steroid-resistant primary FSGS...
  3. pmc A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
    Howard Trachtman
    Division of Nephrology, Department of Pediatrics, Cohen Children s Medical Center, New Hyde Park, New York, USA
    Kidney Int 79:1236-43. 2011
    ..Thus, single-dose fresolimumab was well tolerated in patients with primary resistant FSGS. Additional evaluation in a larger dose-ranging study is necessary...
  4. pmc Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab
    CHRISTINE SETHNA
    Division of Nephrology, Department of Pediatrics, Cohen Children s Medical Center of New York, 269 01 76th Avenue, New Hyde Park, NY 11040, USA
    J Transplant 2011:389542. 2011
    ..No adverse side effects were reported during treatment or followup (mean 22.5 months). Conclusions. Rituximab is a safe and well-tolerated ancillary treatment for recurrent FSGS in pediatric patients in conjunction with plasmapheresis...
  5. pmc Clinical trial of focal segmental glomerulosclerosis in children and young adults
    Debbie S Gipson
    Division of Nephrology, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA
    Kidney Int 80:868-78. 2011
    ..However, the small sample size might have prevented detection of a moderate treatment effect...
  6. doi Evaluation of pediatric patients with mild-to-moderate hypertension: yield of diagnostic testing
    Jonathan Wiesen
    Division of Nephrology, Department of Pediatrics, Schneider Children s Hospital of North Shore LIJ Health System, Long Island Campus, Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA
    Pediatrics 122:e988-93. 2008
    ..We tested the hypothesis that the diagnostic yield of individual components of the currently recommended assessment does not justify performance for all patients with mild-to-moderate hypertension...
  7. doi Nephrotic-range proteinuria in a child with retinoic acid syndrome
    Christine B Sethna
    Division of Nephrology, Department of Pediatrics, Cohen Children s Medical Center of New York, 269 01 76th Avenue, New Hyde Park, NY 11040, USA
    Pediatr Nephrol 27:485-8. 2012
    ....